Contraline (Series A+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$60,000,000
Company Info
Founders
Kevin Eisenfrats
Market
Healthcare & Wellness
Coinvestors
VU Venture Partners
Company Description

A medical device company creating injectable hydrogel designed to provide men with long-lasting contraception. Contraline is developing the first long-lasting, non-hormonal, reversible contraceptive for men